Please try another search
Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
Name | Age | Since | Title |
---|---|---|---|
G. F. Kym Anthony | 67 | 2014 | CEO & Vice Chairman |
Graham Burton | - | 2005 | Co-Founder, Chief Scientific Officer & Director |
Joseph A. Dunn | - | 2009 | Member of Business and Technology Advisory Team |
Jolyon Burton | 47 | 2009 | Member of Business and Technology Advisory Team |
David Hankinson | - | 2005 | Independent Chairman of the Board |
Murray F. McLaughlin | - | 2009 | Member of Business & Technology Advisory Team |
Christopher Newman | - | 2007 | Member of Scientific Advisory Board |
John Oliver | - | 2009 | Chairman of the Business and Technology Advisory Team |
John Brennan | - | 2009 | Member of Business and Technology Advisory Team |
Richard H. Smith | - | 2009 | Member of Business and Technology Advisory Team |
Paul Mesburis | 53 | 2016 | Independent Lead Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review